Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA has entered a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy, and operate AssureChain, a dedicated subnet of MindChain tailored for BlockAssure's insurance and reinsurance operations. The deal, effective October 4, 2026, positions MindWave as BlockAssure's exclusive blockchain provider for AssureChain during the term, with development planned over four quarters. The agreement automatically renews for one-year periods unless either party gives 90 days' notice.
Under the agreement, MindWave will design, develop, security-audit, and deploy AssureChain, then host, operate, and maintain the network. AssureChain will support contracts, policies, premium and payment entries, reinsurance treaties, and claims processing. MindChain will serve as the settlement layer and anchor AssureChain records to Ethereum, providing transparency and traceability. In return, MindWave will receive contracted development fees payable in quarterly installments, with operating and maintenance fees to be agreed upon, plus an allocation equal to 20% of the total supply of AssureCoin, a planned digital token within the MindChain network.
The agreement matters because it marks a significant step in applying blockchain technology to the insurance and reinsurance industry, a sector that has been slow to adopt digital assets. By creating a dedicated subnet for BlockAssure, MindWave is positioning itself at the intersection of blockchain infrastructure and insurance operations, potentially opening new revenue streams and demonstrating the commercial viability of tokenized insurance models. For Apimeds Pharmaceuticals, this deal could enhance its subsidiary's value and diversify its technology portfolio.
MindWave Innovations Inc. USA, a wholly owned subsidiary of Apimeds Pharmaceuticals US, develops technology infrastructure and digital solutions for blockchain-enabled applications, data-driven platforms, and emerging commercial ecosystems. Through projects such as AssureChain, MindWave is expanding the application of its technology into insurance, reinsurance, and digital-asset-enabled insurance models. MindChain, developed within the MindWave ecosystem, is designed to provide the underlying ledger capabilities required for applications involving digital assets, registries, tokenized ecosystems, and decentralized services.
The agreement could serve as a model for other insurers looking to adopt blockchain for claims processing and policy management, reducing fraud and increasing efficiency. It also highlights the growing trend of traditional financial services firms exploring blockchain solutions. For investors, the deal provides insight into Apimeds' strategic direction and the potential of its blockchain subsidiary. The latest news and updates relating to APUS are available in the company's newsroom at Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS).
CryptoCurrencyWire, a specialized communications platform focused on blockchain and cryptocurrency, originally reported the news. As part of the Dynamic Brand Portfolio at IBN, CryptoCurrencyWire delivers access to a vast network of wire solutions via InvestorWire and other services. The full press release can be viewed at https://ccw.fm/bVeq4.
